Mirae Asset Tiger 200 Health Care ETF (KRX:227540)
South Korea · Delayed Price · Currency is KRW 18,240
-60 (-0.33%)
Sep 23, 2026, 3:30 PM KST
KRX:227540 Holdings Information
KRX:227540 is an equity ETF with a total of 10 individual holdings. The top holdings are Samsung Biologics stock at 21.24%, Celltrion at 21.22%, Yuhan at 13.01%, Hanmi Pharm. at 9.83%, and SK Biopharmaceuticals at 9.44%.
Total Holdings
10
Top 10 Percentage
94.68%
Asset Class
Equity
ETF Category
Health Care
Assets
30.06B
PE Ratio
25.41
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 21.24% |
| 2 | KRX: 068270 | Celltrion, Inc. | 21.22% |
| 3 | KRX: 000100 | Yuhan Corporation | 13.01% |
| 4 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 9.83% |
| 5 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 9.44% |
| 6 | KRX: 0126Z0 | Samsung Epis Holdings Co., Ltd. | 5.59% |
| 7 | KRX: 009420 | Hanall Biopharma Co., Ltd. | 5.25% |
| 8 | KRX: 008930 | Hanmi Science Co., Ltd. | 4.22% |
| 9 | KRX: 302440 | SK bioscience Co.,Ltd. | 2.82% |
| 10 | KRX: 006280 | GC Biopharma Corp. | 2.06% |
As of Sep 21, 2026